Multifunctional nanocarriers and intracellular drug delivery

Current Opinion in Solid State and Materials Science

Volumn 16, Issue 6, 2012, Pages 269-275

  Sawant, Rupa R ^a   Torchilin, Vladimir P ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Cell penetrating peptide; Intracellular delivery; Ligand targeted; Long circulating; Multimodal imaging; Nanocarriers; Stimuli sensitive; Theranostics

Indexed keywords

CONTROLLED DRUG DELIVERY; DIAGNOSIS; DISEASE CONTROL; DISEASES;

CELL-PENETRATING PEPTIDE; INTRACELLULAR DELIVERY; LONG CIRCULATING; MULTI-MODAL IMAGING; NANO-CARRIERS; STIMULI-SENSITIVE; THERANOSTICS;

TARGETED DRUG DELIVERY;

EID: 84875238035     PISSN: 13590286     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cossms.2012.09.001     Document Type: Review

References (111)

1. M. Ferrari Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 5 2005 161 171
2. S.K. Hobbs, W.L. Monsky, F. Yuan, W.G. Roberts, L. Griffith, and V.P. Torchilin Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc Natl Acad Sci USA 95 1998 4607 4612
3. R.K. Jain Transport of molecules, particles, and cells in solid tumors Annu Rev Biomed Eng 1 1999 241 263
4. R.K. Jain Delivery of novel therapeutic agents in tumors: physiological barriers and strategies J Natl Cancer Inst 81 1989 570 576
5. F. Yuan, M. Leunig, S.K. Huang, D.A. Berk, D. Papahadjopoulos, and R.K. Jain Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft Cancer Res 54 1994 3352 3356
6. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res 46 1986 6387 6392
7. H. Maeda The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Adv Enzyme Regul 41 2001 189 207
8. H. Maeda SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy Adv Drug Deliv Rev 46 2001 169 185
9. J. Fang, T. Sawa, and H. Maeda Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS Adv Exp Med Biol 519 2003 29 49
10. H. Maeda Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects Bioconjug Chem 21 2010 797 802
11. H. Maeda, G.Y. Bharate, and J. Daruwalla Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect Eur J Pharm Biopharm 71 2009 409 419
12. S. Maki, T. Konno, and H. Maeda Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium Cancer 56 1985 751 757
13. A. Nagamitsu, K. Greish, and H. Maeda Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors Jpn J Clin Oncol 39 2009 756 766
14. W.L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H.A. Weich, and V.P. Torchilin Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor Cancer Res 59 1999 4129 4135
15. R.K. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat Rev Clin Oncol 7 2010 653 664
16. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett 268 1990 235 237
17. C.D. Walkey, J.B. Olsen, H. Guo, A. Emili, and W.C. Chan Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake J Am Chem Soc 134 2012 2139 2147
18. J.L. Perry, K.G. Reuter, M.P. Kai, K.P. Herlihy, S.W. Jones, and J.C. Luft PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics Nano Lett 2012
19. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
20. M.L. Schipper, Z. Cheng, S.W. Lee, L.A. Bentolila, G. Iyer, and J. Rao MicroPET-based biodistribution of quantum dots in living mice J Nucl Med 48 2007 1511 1518
21. T. Ishida, M. Ichihara, X. Wang, K. Yamamoto, J. Kimura, and E. Majima Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes J Control Release 112 2006 15 25
22. T. Ishida, K. Atobe, X. Wang, and H. Kiwada Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin- encapsulation and high-dose first injection J Control Release 115 2006 251 258
23. K.R. Whiteman, V. Subr, K. Ulbrich, and V.P. Torchilin Poly(Hpma)-coated liposomes demonstrate prolonged circulation in mice J Liposome Res 11 2001 153 164
24. V.P. Torchilin, T.S. Levchenko, K.R. Whiteman, A.A. Yaroslavov, A.M. Tsatsakis, and A.K. Rizos Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification Biomaterials 22 2001 3035 3044
25. H. Takeuchi, H. Kojima, H. Yamamoto, and Y. Kawashima Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats J Control Release 75 2001 83 91
26. V.P. Torchilin, A.L. Klibanov, L. Huang, S. O'Donnell, N.D. Nossiff, and B.A. Khaw Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium Faseb J 6 1992 2716 2719
27. G. Blume, and G. Cevc Molecular mechanism of the lipid vesicle longevity in vivo Biochim Biophys Acta 1146 1993 157 168
28. R.M. Abra, R.B. Bankert, F. Chen, N.K. Egilmez, K. Huang, and R. Saville The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients J Liposome Res 12 2002 1 3
29. G. Trapani, N. Denora, A. Trapani, and V. Laquintana Recent advances in ligand targeted therapy J Drug Target 20 2012 1 22
30. R.R. Sawant, and V.P. Torchilin Challenges in development of targeted liposomal therapeutics AAPS J 14 2012 303 315
31. V. Torchilin Multifunctional and stimuli-sensitive pharmaceutical nanocarriers Eur J Pharm Biopharm 71 2009 431 444
32. V.P. Torchilin Multifunctional nanocarriers Adv Drug Deliv Rev 58 2006 1532 1555
33. J.L. Wike-Hooley, J. Haveman, and H.S. Reinhold The relevance of tumour pH to the treatment of malignant disease Radiother Oncol 2 1984 343 366
34. F. Kallinowski, K.H. Schlenger, S. Runkel, M. Kloes, M. Stohrer, and P. Okunieff Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts Cancer Res 49 1989 3759 3764
35. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation Nat Med 3 1997 177 182
36. L.E. Gerweck, and K. Seetharaman Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer Cancer Res 56 1996 1194 1198
37. T. Yoshimura, M. Shono, K. Imai, and K. Hong Kinetic analysis of endocytosis and intracellular fate of liposomes in single macrophages J Biochem 117 1995 34 41
38. G. Saito, J.A. Swanson, and K.D. Lee Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities Adv Drug Deliv Rev 55 2003 199 215
39. R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen, and Z. Zhong Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery J Control Release 152 2011 2 12
40. D. Needham, G. Anyarambhatla, G. Kong, and M.W. Dewhirst A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res 60 2000 1197 1201
41. L. Zhu, Z. Huo, L. Wang, X. Tong, Y. Xiao, and K. Ni Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes Int J Pharm 370 2009 136 143
42. C. Alexiou, W. Arnold, R.J. Klein, F.G. Parak, P. Hulin, and C. Bergemann Locoregional cancer treatment with magnetic drug targeting Cancer Res 60 2000 6641 6648
43. A. Schroeder, R. Honen, K. Turjeman, A. Gabizon, J. Kost, and Y. Barenholz Ultrasound triggered release of cisplatin from liposomes in murine tumors J Control Release 137 2009 63 68
44. J.Y. Legendre, and F.C. Szoka Jr. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes Pharm Res 9 1992 1235 1242
45. I.M. Hafez, and P.R. Cullis Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior Biochim Biophys Acta 1463 2000 107 114
46. V.A. Slepushkin, S. Simoes, P. Dazin, M.S. Newman, L.S. Guo, and M.C. Pedroso de Lima Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo J Biol Chem 272 1997 2382 2388
47. C. Plank, B. Oberhauser, K. Mechtler, C. Koch, and E. Wagner The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems J Biol Chem 269 1994 12918 12924
48. S. Simoes, V. Slepushkin, R. Gaspar, M.C. de Lima, and N. Duzgunes Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides Gene Ther 5 1998 955 964
49. K. Sasaki, K. Kogure, S. Chaki, Y. Nakamura, R. Moriguchi, and H. Hamada An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives Anal Bioanal Chem 391 2008 2717 2727
50. E.M. Stier, M. Mandal, and K.D. Lee Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells Mol Pharm 2 2005 74 82
51. D.C. Drummond, M. Zignani, and J. Leroux Current status of pH-sensitive liposomes in drug delivery Prog Lipid Res 39 2000 409 460
52. E. Roux, M. Lafleur, E. Lataste, P. Moreau, and J.C. Leroux On the characterization of pH-sensitive liposome/polymer complexes Biomacromolecules 4 2003 240 248
53. M.A. Yessine, and J.C. Leroux Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules Adv Drug Deliv Rev 56 2004 999 1021
54. R.A. Jones, C.Y. Cheung, F.E. Black, J.K. Zia, P.S. Stayton, and A.S. Hoffman Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles Biochem J 372 2003 65 75
55. T.R. Kyriakides, C.Y. Cheung, N. Murthy, P. Bornstein, P.S. Stayton, and A.S. Hoffman PH-sensitive polymers that enhance intracellular drug delivery in vivo J Control Release 78 2002 295 303
56. O. Meyer, D. Papahadjopoulos, and J.C. Leroux Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes FEBS Lett 421 1998 61 64
57. M. Zignani, D.C. Drummond, O. Meyer, K. Hong, and J.C. Leroux In vitro characterization of a novel polymeric-based pH-sensitive liposome system Biochim Biophys Acta 1463 2000 383 394
58. K. Kono, K. Zenitani, and T. Takagishi Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups Biochim Biophys Acta 1193 1994 1 9
59. T. Mizoue, T. Horibe, K. Maruyama, T. Takizawa, M. Iwatsuru, and K. Kono Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells Int J Pharm 237 2002 129 137
60. N. Sakaguchi, C. Kojima, A. Harada, and K. Kono Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH Bioconjug Chem 19 2008 1040 1048
61. R.M. Straubinger, N. Duzgunes, and D. Papahadjopoulos PH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules FEBS Lett 179 1985 148 154
62. S. Simoes, J.N. Moreira, C. Fonseca, N. Duzgunes, and M.C. de Lima On the formulation of pH-sensitive liposomes with long circulation times Adv Drug Deliv Rev 56 2004 947 965
63. I.Y. Kim, Y.S. Kang, D.S. Lee, H.J. Park, E.K. Choi, and Y.K. Oh Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice J Control Release 140 2009 55 60
64. L. Xu, C.C. Huang, W. Huang, W.H. Tang, A. Rait, and Y.Z. Yin Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes Mol Cancer Ther 1 2002 337 346
65. G. Shi, W. Guo, S.M. Stephenson, and R.J. Lee Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations J Control Release 80 2002 309 319
66. J.J. Sudimack, W. Guo, W. Tjarks, and R.J. Lee A novel pH-sensitive liposome formulation containing oleyl alcohol Biochim Biophys Acta 1564 2002 31 37
67. J.W. Holland, C. Hui, P.R. Cullis, and T.D. Madden Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine Biochemistry 35 1996 2618 2624
68. V. Toncheva, E. Schacht, S.Y. Ng, J. Barr, and J. Heller Use of block copolymers of poly(ortho esters) and poly (ethylene glycol) micellar carriers as potential tumour targeting systems J Drug Target 11 2003 345 353
69. J. Shin, P. Shum, and D.H. Thompson Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids J Control Release 91 2003 187 200
70. M. Gumusderelioglu, and D. Kesgin Release kinetics of bovine serum albumin from pH-sensitive poly(vinyl ether) based hydrogels Int J Pharm 288 2005 273 279
71. F. Kratz, U. Beyer, T. Roth, M.T. Schutte, A. Unold, and H.H. Fiebig Albumin conjugates of the anticancer drug chlorambucil: synthesis, characterization, and in vitro efficacy Arch Pharm (Weinheim) 331 1998 47 53
72. U. Beyer, T. Roth, P. Schumacher, G. Maier, A. Unold, and A.W. Frahm Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil J Med Chem 41 1998 2701 2708
73. W.C. Shen, and H.J. Ryser Cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate Biochem Biophys Res Commun 102 1981 1048 1054
74. J.R. Ogden, K. Leung, S.A. Kunda, M.W. Telander, B.P. Avner, and S.K. Liao Immunoconjugates of doxorubicin and murine antihuman breast carcinoma monoclonal antibodies prepared via an N-hydroxysuccinimide active ester intermediate of cis-aconityl-doxorubicin: preparation and in vitro cytotoxicity Mol Biother 1 1989 170 174
75. E.R. Gillies, T.B. Jonsson, and J.M. Frechet Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers J Am Chem Soc 126 2004 11936 11943
76. E.R. Gillies, and J.M. Frechet PH-responsive copolymer assemblies for controlled release of doxorubicin Bioconjug Chem 16 2005 361 368
77. M.J. Heffernan, and N. Murthy Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle Bioconjug Chem 16 2005 1340 1342
78. M. Oishi, Y. Nagasaki, K. Itaka, N. Nishiyama, and K. Kataoka Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells J Am Chem Soc 127 2005 1624 1625
79. M.C. Parrott, J.C. Luft, J.D. Byrne, J.H. Fain, M.E. Napier, and J.M. Desimone Tunable bifunctional silyl ether cross-linkers for the design of acid-sensitive biomaterials J Am Chem Soc 132 2010 17928 17932
80. S. Biswas, N.S. Dodwadkar, R.R. Sawant, and V.P. Torchilin Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization Bioconjug Chem 22 2011 2005 2013
81. X. Yang, J.J. Grailer, S. Pilla, D.A. Steeber, and S. Gong Tumor-targeting, pH-responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy Bioconjug Chem 21 2010 496 504
82. M. Shen, Y. Huang, L. Han, J. Qin, X. Fang, and J. Wang Multifunctional drug delivery system for targeting tumor and its acidic microenvironment J Control Release 161 2012 884 892
83. J.K. Willmann, N. van Bruggen, L.M. Dinkelborg, and S.S. Gambhir Molecular imaging in drug development Nat Rev Drug Discov 7 2008 591 607
84. A. Louie Multimodality imaging probes: design and challenges Chem Rev 110 2010 3146 3195
85. J. Zheng, J. Liu, M. Dunne, D.A. Jaffray, and C. Allen In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications Pharm Res 24 2007 1193 1201
86. S. Santra, C. Kaittanis, J. Grimm, and J.M. Perez Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging Small 5 2009 1862 1868
87. F.M. Kievit, O. Veiseh, C. Fang, N. Bhattarai, D. Lee, and R.G. Ellenbogen Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma ACS Nano 4 2010 4587 4594
88. Z. Medarova, W. Pham, Y. Kim, G. Dai, and A. Moore In vivo imaging of tumor response to therapy using a dual-modality imaging strategy Int J Cancer 118 2006 2796 2802
89. Z. Medarova, L. Rashkovetsky, P. Pantazopoulos, and A. Moore Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging Cancer Res 69 2009 1182 1189
90. M. Kumar, M. Yigit, G. Dai, A. Moore, and Z. Medarova Image-guided breast tumor therapy using a small interfering RNA nanodrug Cancer Res. 70 2010 7553 7561
91. Z. Medarova, W. Pham, C. Farrar, V. Petkova, and A. Moore In vivo imaging of siRNA delivery and silencing in tumors Nat Med 13 2007 372 377
92. H. Koo, H. Lee, S. Lee, K.H. Min, M.S. Kim, and D.S. Lee In vivo tumor diagnosis and photodynamic therapy via tumoral pH-responsive polymeric micelles Chem Commun (Camb) 46 2010 5668 5670
93. T.Y. Lin, H. Zhang, J. Luo, Y. Li, T. Gao, and P.N. Lara Jr. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer Int J Nanomed 7 2012 2793 2804
94. T. Liu, X. Li, Y. Qian, X. Hu, and S. Liu Multifunctional pH-disintegrable micellar nanoparticles of asymmetrically functionalized beta-cyclodextrin-based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties Biomaterials 33 2012 2521 2531
95. V.G. Deepagan, B. Sarmento, D. Menon, A. Nascimento, A. Jayasree, and M. Sreeranganathan In vitro targeted imaging and delivery of camptothecin using cetuximab-conjugated multifunctional PLGA-ZnS nanoparticles Nanomedicine (Lond) 7 2012 507 519
96. J.M. Li, Y.Y. Wang, M.X. Zhao, C.P. Tan, Y.Q. Li, and X.Y. Le Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking Biomaterials 33 2012 2780 2790
97. R. Hardman A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors Environ Health Perspect 114 2006 165 172
98. G.D. Kenny, N. Kamaly, T.L. Kalber, L.P. Brody, M. Sahuri, and E. Shamsaei Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo J Control Release 149 2011 111 116
99. D.E. Lee, H. Koo, I.C. Sun, J.H. Ryu, K. Kim, and I.C. Kwon Multifunctional nanoparticles for multimodal imaging and theragnosis Chem Soc Rev 41 2012 2656 2672
100. R. Sawant, and V. Torchilin Intracellular transduction using cell-penetrating peptides Mol Biosyst 6 2010 628 640
101. V.P. Torchilin Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 90 2008 604 610
102. J. Grunwald, T. Rejtar, R. Sawant, Z. Wang, and V.P. Torchilin TAT peptide and its conjugates: proteolytic stability Bioconjug Chem 20 2009 1531 1537
103. R.M. Sawant, J.P. Hurley, S. Salmaso, A. Kale, E. Tolcheva, and T.S. Levchenko "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers Bioconjug Chem 17 2006 943 949
104. E. Koren, A. Apte, A. Jani, and V.P. Torchilin Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity J Control Release 2011
105. L. Zhu, P. Kate, and V.P. Torchilin Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting ACS Nano 6 2012 3491 3498
106. X.B. Xiong, and A. Lavasanifar Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin ACS Nano 5 2011 5202 5213
107. V.A. Sethuraman, and Y.H. Bae TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors J Control Release 118 2007 216 224
108. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, and O.M. Girard Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 16 2009 510 520
109. T. Teesalu, K.N. Sugahara, V.R. Kotamraju, and E. Ruoslahti C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc Natl Acad Sci USA 106 2009 16157 16162
110. D.W. Bartlett, H. Su, I.J. Hildebrandt, W.A. Weber, and M.E. Davis Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc Natl Acad Sci USA 104 2007 15549 15554
111. D.B. Kirpotin, D.C. Drummond, Y. Shao, M.R. Shalaby, K. Hong, and U.B. Nielsen Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res 66 2006 6732 6740